DNA alkylation and DNA methylation: Cooperating mechanisms driving the formation of colorectal adenomas and adenocarcinomas?

Gut

Volumn 56, Issue 3, 2007, Pages 318-320

  Grady, William M ^a,b,c   Ulrich, Cornelia M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MUTAGENIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; DNA;

CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; COLORECTAL ADENOCARCINOMA; COLORECTAL ADENOMA; COLORECTAL CANCER; CORRELATION ANALYSIS; DNA ALKYLATION; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; ETHNIC DIFFERENCE; FOOD INTAKE; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NONHUMAN; NOTE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; VEGETABLE; X CHROMOSOME INACTIVATION; ADENOCARCINOMA; ADENOMA; ALKYLATION; CELL TRANSFORMATION; COLORECTAL TUMOR; CPG ISLAND; GENETICS;

ADENOCARCINOMA; ADENOMA; ALKYLATION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; HUMANS;

EID: 34047178288     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.106849     Document Type: Note

References (29)

1. Sjoblom T, Jones S, Wood LD, et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers. Science 2006;314:268-74.
2. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-99.
3. Veigl M, Kasturi L, Olechnowicz J, et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci 1998;95:8698-702.
4. Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004;36:417-22.
5. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38:787-93.
6. Grady WM, Markowitz SD. Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 2002;3:101-28.
7. Jass JR. Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol 2004;2:1-8.
8. Jass JR, Whitehall VL, Young J, et al. Emerging concepts in colorectal neoplasia. Gastroenterology 2002;123:862-76.
9. Baker K, Zhang Y, Jin C, et al. Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? J Clin Pathol 2004;57:1089-93.
10. Povey AC, Badawi AF, Cooper DP, et al. DNA alkylation and repair in the large bowel: animal and human studies. J Nutr 2002;132:3518S-21S.
11. Engelbergs J, Thomale J, Rajewsky MF. Role of DNA repair in carcinogen-induced ras mutation. Mutat Res 2000;450:139-53.
12. Lees NP, Harrison KL, Hill E, et al. Heterogeneity of O(6)-alkylguanine-DNA alkyltransferase activity in colorectal cancer: implications for treatment. Oncology 2002;63:393-7.
13. Srivenugopal KS, Yuan XH, Friedman HS, et al. Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2-chloroerhyl)-1-nitrosourea. Biochemistry 1996;35:1328- 34.
14. Lees NP, Harrison KL, Hill E, et al. Longitudinal variation in O(6)-alkylguanine DNA-alkyltransferase activity in the human colon and rectum. Br J Cancer 2002;87:168-70.
15. Lees NP, Harrison KL, Hall CN, et al. Human colorectal mucosal O6-alkylguanine DNA-alkyltransferase activity and DNA-N7-methylguanine levels in colorectal adenoma cases and matched referents. Gut 2007;56:380-4.
16. Margison GP, Heighway J, Pearson S, et al. Quantitative trait locus analysis reveals two intragenic sites that influence O6-alkylguanine-DNA alkyltransferase activity in peripheral blood mononuclear cells. Carcinogenesis 2005;26:1473-80.
17. Yang M, Coles BF, Caporaso NE, et al. Lack of association between Caucasian lung cancer risk and O6-methylguanine-DNA methyltransferase- codon 178 genetic polymorphism. Lung Cancer 2004;44:281-6.
18. Cohet C, Borel S, Nyberg F, et al. Exon 5 polymorphisms in the O6-alkylguanine DNA alkyltransferase gene and lung cancer risk in non-smokers exposed to second-hand smoke. Cancer Epidemiol Biomarkers Prev 2004;13:320-3.
19. Berardini M, Mazurek A, Fishel R. The effect of O6-methylguanine DNA adducts on the adenosine nucleotide switch functions of hMSH2-hMSH6 and hMSH2-hMSH3. J Biol Chem 2000;275:27851-7.
20. Povey AC, Hall CN, Badowi AF, et al. Host determinants of DNA alleviation and DNA repair activity in human colorectal tissue: O(6)-methylguanine levels are associated with GSTT1 genotype and O(6)-alkylguanine-DNA alkyltransferase activity with CYP2D6 genotype. Mutat Res 2001;495:103-15.
21. Margison GP, Povey AC, Kaina B, et al. Variability and regulation of O6-alkylguanine-DNA alkyltransferase. Carcinogenesis 2003;24:625-35.
22. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000;16:168-74.
23. Chan AO, Broaddus RR, Houlihan PS, et al. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 2002;160:1823-30.
24. Kim YH, Petko Z, Dzieciatkowski S, et al. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 2006;45:781-9.
25. Shen L, Kondo Y, Rosner GL, et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005;97:1330-8.
26. Ahuja N, Issa JP. Aging, methylation and cancer. Histol Histopathol 2000;15:835-42.
27. Ahuja N, Li Q, Mohan M, et al. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998;58:5489-94.
28. Kane M, Loda M, Gaida G, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Research 1997;57:808-11.
29. Bierie B, Moses HL. TGF-beta and cancer. Cytokine Growth Factor Rev 2006;17:29-40.